Skip to main content
SpringerLink
Log in

Verbesserung der Spezifität des prostataspezifischen Antigens

  • Kontroversen in der Uro-Onkologie
  • Published:
Der Urologe B

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Benson MC, Ring KS, Olsson CA (1989) The determination of stage D-0 carcinoma of the prostate using PSA density. Urologist’s Correspondence Club, September 24

  2. Berry SJ, Coffey DS, Walsh PC, Ewing LL (1984) The development of human benign prostatic hyperplasia with age. J Urol 132: 474–479

    CAS  PubMed  Google Scholar 

  3. Carter HB, Pearson JD, Metter EJ, Brant LJ, Chan DW, Andres R, Fozard JL, Walsh PC (1992) Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 267: 2215–2220

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Froschermaier SE, Pilarsky CP, Wirth MP (1996) Clinical significance of the determination of noncomplexed prostate-specific antigen as a marker for prostate carcinoma. Urology 47: 525–528

    Article  CAS  PubMed  Google Scholar 

  5. Hammerer PG, McNeal JE, Stamey TA (1995) Correlation between serum prostate specific antigen levels and the volume of the individual glandular zones of the human prostate. J Urol 153: 111–114

    Article  CAS  PubMed  Google Scholar 

  6. Huber PR, Schmid H-P, Mattarelli G, Strittmatter B, van Steenbrugge GJ, Maurer A (1995) Serum free prostate-specific antigen: isoenzymes in benign hyperplasia and cancer of the prostate. Prostate 27: 212–219

    Article  CAS  PubMed  Google Scholar 

  7. Kalish J, Cooner WH, Graham SD Jr (1994) Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate. Urology 43: 601–606

    Article  CAS  PubMed  Google Scholar 

  8. Lilja H, Christensson A, Dahlen U, Matikainen M-T, Nilsson O, Pettersson K, Loevgren T (1991) Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. Clin Chem 37: 1618–1625

    CAS  PubMed  Google Scholar 

  9. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, Lieber MM (1993) Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA 279: 860–864

    Article  Google Scholar 

  10. Schmid H-P, McNeal JE, Stamey TA (1993) Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume. Cancer 71: 2031–2040

    Article  CAS  PubMed  Google Scholar 

  11. Schmid H-P, Ravery V, Billebaud T, Toublanc M, Boccon-Gibod LA, Hermieu JF, Delmas V, Boccon-Gibod L (1996) Early detection of prostate cancer in men with prostatism and intermediate prostate-specific antigen levels. Urology 47: 699–703

    Article  CAS  PubMed  Google Scholar 

  12. Semjonow A, Hamm M, Rathert P, Hertle L (1994) Prostate-specific antigen corrected for prostate volume improves differentiation of benign prostatic hyperplasia and organ-confined prostatic cancer. Br J Urol 73: 538–543

    Article  CAS  PubMed  Google Scholar 

  13. Stamey TA, McNeal JE (1992) Adenocarcinoma of the prostate. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED Jr (eds) Campbell’s urology. Saunders, Philadelphia, pp 1159–1221

  14. Stenman U-H, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O (1991) A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 51: 222–226

    CAS  PubMed  Google Scholar 

  15. Stephan C, Lein M, Jung K, Schnorr D, Loening SA (1997) The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia. Cancer 79: 104–109

    Article  CAS  PubMed  Google Scholar 

  16. Zlotta AR, Djavan B, Marberger M, Schulman CC (1997) Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction. J Urol 157: 1315–1321

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Urologische Universitätsklinik, Inselspital, CH-3010, Bern

    H. P. Schmid

Authors
  1. H. P. Schmid
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schmid, H.P. Verbesserung der Spezifität des prostataspezifischen Antigens. Der Urologe B 38, S46–S48 (1998). https://doi.org/10.1007/BF03351087

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03351087

Search

Navigation